Skip to content

The effect of ozonated autohemotherapy on sleep quality after laparoscopy in female patients with preoperative insomnia

The effect of ozonated autohemotherapy on sleep quality after laparoscopy in female patients with preoperative insomnia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092263
Enrollment
Unknown
Registered
2024-11-13
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep disorders

Interventions

the ozonated autohemotherapy group(the O3-AHT group):ozonated autohemotherapy
control group:autologous blood donation

Sponsors

Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Age: 18-45 ; gender: female; 2.Able to take care of themselves in their daily lives, with an Activity of Daily Living (ADL) score >60; 3.Able to understand, read and write Chinese normally, with a score of >=27 on Mini-mental State Examination(MMSE); 4.No clinical manifestations of perimenopausal syndrome; 5.Laparoscopic surgery under general anaesthesia with elective tracheal intubation; 6.American Society of Anaesthesiologists (ASA) I-III; 7.It was anticipated that intraoperative bleeding would exceed 150ml and that acute isovolumic haemodilution would not be required, provided there were no contraindications. The patient's general physical condition was deemed to be satisfactory, with a haemoglobin concentration of at least 110g/L (haematocrit of 0.33). Furthermore, the technique could be employed in instances where surgery was necessary to reduce blood viscosity and enhance microcirculation. 8.insomnia: Pittsburgh sleep quality index (PSQI) score >7 and Insomnia Severity Index (ISI) >=15.

Exclusion criteria

Exclusion criteria: 1.Chronic use of sedatives, antidepressants, drug or alcohol dependence, acute alcoholism; 2.Fava bean disease: glucose-6-phosphate dehydrogenase deficiency; 3.Toxic diffuse goitre (Graves' disease); 4.Patients with haemochromatosis, copper or iron therapy; 5.pregnancies; 6.Anticoagulant (sodium citrate) allergy;

Design outcomes

Primary

MeasureTime frame
Pittsburgh sleep quality index, PSQI;

Secondary

MeasureTime frame
Insomnia Severity Index;sleep quality numerical rating scale;visual analogue scale;

Countries

China

Contacts

Public ContactQian Qian

Zhujiang Hospital of Southern Medical University

2339202482@qq.com+86 20 62782858

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026